Main

type

5 (blog/news article)

status

21 (imported old-v2, waiting for another import)

review version

0

cleanup version

0

pending deletion

0 (-)

created at

2025-10-28 15:04:14

updated at

2025-12-10 18:28:45

Address

url

https://www.amgen.com/newsroom/press-releases/2007/05/amgen-oncology-highlights-upcoming-data-presentations-at-the-american-society-of-clinical-oncology-asco-annual-meeting

url length

172

url crc

15642

url crc32

3302833434

location type

1 (url matches target location, page_location is empty)

canonical status

10 (verified canonical url)

canonical page id

-

Source

domain id

5169700

domain tld

2211

domain parts

0

originating warc id

-

originating url

https://www-ext.amgen.com/newsroom/press-releases/2007/05/amgen-oncology-highlights-upcoming-data-presentations-at-the-american-society-of-clinical-oncology-asco-annual-meeting

source type

10 (canonical url)

Server response

server ip

18.64.67.22

Publication date

2025-08-05 03:45:31

Fetch attempts

0

Original html size

168628

Normalized and saved size

147792

Content

title

Amgen Oncology Highlights Upcoming Data Presentations at the American Society of Clinical Oncology (ASCO) Annual Meeting| Amgen

excerpt

content


 
 
 
 
 
 Amgen Oncology Highlights Upcoming Data Presentations at the American Society of Clinical Oncology (ASCO) Annual Meeting
 
 
 Clinical Data to be Presented on Seven Investigational Targeted and Supportive Care Cancer Therapies from Oncology Pipeline THOUSAND OAKS, Calif., May 29, 2007 (BUSINESS WIRE) -- Amgen (NASDAQ:AMGN), today announced upcoming data presentations
 of interest at the 43rd Annual American Society of Clinical Oncology
 (ASCO) Meeting in Chicago.
 Clinical data will be presented on seven investigational
 therapies: AMG 531 in thrombocytopenic patients with myelodysplastic
 syndrome (MDS), motesanib diphosphate (AMG 706) in locally advanced or
 metastatic thyroid cancer; and AMG 102, AMG 386, AMG 479, AMG 655, and
 rhApo2L/TRAIL in patients with advanced solid tumors. This is the
 first time that Phase 1 clinical data for AMG 102, AMG 386, AMG 479
...

author

updated

1768366335

Text analysis

block type

0

extracted fields

105

extracted bits

featured image
title
full content
content was extracted heuristically

detected location

0

detected language

1 (English)

category id

-

index version

1

paywall score

0

spam phrases

0

Text statistics

text nonlatin

0

text cyrillic

0

text characters

13428

text words

2468

text unique words

803

text lines

1

text sentences

99

text paragraphs

1

text words per sentence

24

text matched phrases

0

text matched dictionaries

0